ABBVIE INC. vs. Pfizer Inc.
ABBVIE INC. (ABBV) comes out ahead, leading on 7 of 11 compared factors.
Size & Scale
| ABBV | PFE | |
|---|---|---|
| Market Cap | $470.00 billion | $160.96 billion |
| Revenue (TTM) | $64.39 billion | $63.70 billion |
| Net Income (TTM) | $6.32 billion | $4.37 billion |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | PFE | |
|---|---|---|
| P/E Ratio | 75.06 | 36.76 |
| Price / Book | -79.82 | 1.88 |
| Price / Sales | 7.30 | 2.53 |
PFE leads on 2 of 3 valuation factors.
Profitability
| ABBV | PFE | |
|---|---|---|
| Net Margin | 9.81% | 6.86% |
| Return on Equity | -107.29% | 5.11% |
ABBV and PFE split the profitability factors evenly.
Dividend
| ABBV | PFE | |
|---|---|---|
| Dividend Yield | 2.60% | 6.16% |
| Payout Ratio | 195.48 | 226.32 |
ABBV and PFE split the dividend factors evenly.
Risk & Sentiment
| ABBV | PFE | |
|---|---|---|
| Short Interest | 0.85% | 0.88% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, PFE overview, PFE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.